HER2, HER3, and TROP2: Diagnostic Testing and Treatment Implications in Breast, GI, and Lung Cancers

Review the latest expert guidance on assessing and targeting HER2 HER3 and TROP2 in the metastatic setting for diverse malignancies with on-demand Webcasts and downloadable slides from CCO&rsquo s live Webinars along with expert-authored commentaries a pocket guide on best practices for testing and brief Medical Minute slide/audio presentations for oncologists and pathologists.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.